EGLAX
Price
$13.18
Change
+$0.18 (+1.38%)
Updated
Jul 13 closing price
Net Assets
269.14M
SMRPX
Price
$12.63
Change
+$0.16 (+1.28%)
Updated
Jul 13 closing price
Net Assets
1.42B
Interact to see
Advertisement

EGLAX vs SMRPX

EGLAX vs SMRPX Comparison Chart in %
View a ticker or compare two or three
VS
EGLAX vs. SMRPX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EGLAX is a StrongBuy and SMRPX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SMRPX has more cash in the bank: 1.42B vs. EGLAX (269M). EGLAX pays higher dividends than SMRPX: EGLAX (4.14) vs SMRPX (3.82). EGLAX was incepted earlier than SMRPX: EGLAX (14 years) vs SMRPX (11 years). EGLAX (1.92) is less costly to investors than SMRPX (1.03). SMRPX is a more actively managed with annual turnover of: 52.00 vs. EGLAX (32.00). EGLAX has a lower initial minimum investment than SMRPX: EGLAX (2500) vs SMRPX (1000000). EGLAX annual gain was more profitable for investors over the last year : 31.03 vs. SMRPX (26.16). EGLAX return over 5 years is better than : 214.57 vs. SMRPX (141.92).
EGLAXSMRPXEGLAX / SMRPX
Total Expense Ratio1.650.99167%
Annual Report Gross Expense Ratio1.921.03186%
Fund Existence14 years11 years-
Gain YTD28.74022.976125%
Front Load6%N/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets269M1.42B19%
Annual Yield % from dividends4.143.82108%
Returns for 1 year31.0326.16119%
Returns for 3 years108.5191.84118%
Returns for 5 years214.57141.92151%
Returns for 10 years198.70149.78133%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EISDX37.01N/A
N/A
Carillon ClariVest Intl Stock C
FRCSX72.36N/A
N/A
Franklin Small Cap Value R6
TRCSX20.82N/A
N/A
T. Rowe Price Small-Cap Index I
ABIYX21.43N/A
N/A
AB International Value Advisor
RAFBX35.43-0.41
-1.14%
American Funds AMCAP R-2